Allogeneic Transplant Outcomes in Patients Aged ≥70 Vs <70 with Fludarabine/Melphalan Conditioning and Post-Transplant Cyclophosphamide

Key Points

• Older patients show differential outcomes post-allogeneic transplant, particularly with specific conditioning regimens.
• Key metrics indicate that age impacts overall survival rates and transplant success, emphasizing the need for tailored approaches.
• Observational analysis focusing on patients receiving fludarabine and melphalan conditioning, followed by cyclophosphamide.
• The findings suggest that further investigation is needed to refine treatment strategies for older transplant candidates.